Most Popular Papers *
Adoptive cellular therapy in acute myeloid leukemia: Current scope and challenges
Sankalp Arora, Palash Asawa, Aravind Ramakrishnan, Carlos Bachier, and Navneet S Majhail
CAR-T cell Therapies for B-cell Lymphoid Malignancies: Identifying Targets Beyond CD19
Yenny M. Vanegas, Razan Mohty, Martha E. Gadd, Yan Luo, Mahmoud Aljurf, Hong Qin, and Mohamed A. Kharfan-Dabaja
Next-Generation Chimeric Antigen Receptor T Cells
Dongni Yi, Mia Gergis, Jingmei Hsu, Yang Yang, Xia Bi, Mahmoud Aljurf, and Usama Gergis
Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies
Yang Yang, Xia Bi, Mia Gergis, Dongni Yi, Jingmei Hsu, and Usama Gergis
Chimeric Antigen Receptor T-Cell Therapies in Lymphoma Patients with Central Nervous System Involvement
Dongni Yi, Mia Gergis, Ghada Elgohary, Jingmei Hsu, Yang Yang, Xia Bi, and Usama Gergis
Clinical utility of neutrophil to lymphocyte ratio in sickle cell disease with vaso-occlusive crisis
Satish Maharaj and Simone Chang
Use of checkpoint inhibitors in gray zone lymphoma
Yensy Mariana Zelaya Rosales, Juliene Lima Mesquita, Yhasmine Delles Oliveira Garcia, Fernando Ricardo Fernandes Paz, Naiana Castelo Branco Campos, Joa˜o Paulo de Vasconcelos Leita˜o, Francisco Da´rio Rocha Filho, Ricardo Vale Albino Oliveira Filho, Rome´lia Pinheiro Gonc¸alves Lemes, and Fernando Barroso Duarte
Chimeric antigen receptor T cell therapy for solid tumors
Jingmei Hsu, Yang Yang, Mia Gergis, Xia Bi, Dongni Yi, and Usama Gergis
Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?
Imran K. Tailor, Nawal F. Alshehry, Syed Z. Zaidi, Mohammed A. Marei, Ibraheem H. Motabi, Mansour Alfayez, and Syed Y. Altaf
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia
Xia Bi, Jingmei Hsu, Mia Gergis, Yang Yang, Dongni Yi, and Usama Gergis
* Based on the average number of full-text downloads per day since the paper was posted.
» Updated as of 01/14/23.
